|

Taxotere (docetaxel) Clinical Trials

2 actively recruiting trials

Also known as: Taxotere

Pipeline

Phase 3: 1

Top Sponsors

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
  • CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1

Indications

  • Cancer2
  • Castrate Sensitive Prostate Cancer1
  • Metastatic Cancer1
  • Gastric Cancer1
  • Prostate Cancer1

Other2 trials

A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer
Phase 3
PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate Cancer

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.